摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[2-(3,4-dimethoxyphenyl)ethyl](isobutylidene)amine | 459831-95-9

中文名称
——
中文别名
——
英文名称
[2-(3,4-dimethoxyphenyl)ethyl](isobutylidene)amine
英文别名
N-[2-(3,4-dimethoxyphenyl)ethyl]-2-methylpropan-1-imine
[2-(3,4-dimethoxyphenyl)ethyl](isobutylidene)amine化学式
CAS
459831-95-9
化学式
C14H21NO2
mdl
——
分子量
235.326
InChiKey
KFDBLQVMVGRMJR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    17
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    30.8
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as Potent Carbonic Anhydrase Inhibitors: Synthesis, Biological Evaluation, and Enzyme−Ligand X-ray Studies
    摘要:
    Following previous studies we herein report the exploration of the carbonic anhydrase (CA, EC 4.2.1.1) inhibitory effects and enzyme selectivity of a small class of 1-(cyclo)alkylisoquinolines containing a sulfonamide function considered a key feature for inhibiting CA. The results of enzymatic assays against human (h) CA isoforms, hCA I and hCA II (cytosolic, ubiquitous enzymes), hCA IX (transmembrane, tumor-associated), and hCA XIV (transmembrane), suggested that the presence of C-1 small substituents on isoquinoline scaffold controls both inhibitory potency and selectivity. Some derivatives showed potent hCA IX and hCA. XIV inhibitory effects at nanomolar concentrations as well as low affinity for the ubiquitous hCA II. Moreover, we report the X-ray crystal structure of one of these derivatives in complex with dominant human isoform II, thus confirming the sulfonamide zinc interactions. Finally, the results of docking experiments suggested the hypothetic interactions in the catalytic binding site for the most active and selective hCA IX and hCA XIV inhibitor.
    DOI:
    10.1021/jm9014026
  • 作为产物:
    描述:
    3,4-二甲氧基苯乙胺异丁醛 反应 1.5h, 以80%的产率得到[2-(3,4-dimethoxyphenyl)ethyl](isobutylidene)amine
    参考文献:
    名称:
    α-亚磺酰胺的串联Pummerer / Mannich环化级联反应是制备氮杂杂环的方法。
    摘要:
    通过伯胺与酮的缩合,然后使所得的亚胺与乙基亚磺酰基乙酰氯反应,然后用高碘酸钠氧化,可以方便地制备一系列α-亚磺酰胺基。当用p-TsOH处理时,通过涉及初始Pummerer反应,随后将所得N-酰基亚胺离子随后环化到束缚的芳族环上的机理发生环化以产生稠合的异喹啉内酰胺。根据Nazarov型4pi-电环反应,然后将pi环化到N-酰基亚胺离子受阻最小的一侧,合理化了单个非对映异构体的分离。用于产生α-酰基硫鎓离子中间体的另一种方法涉及双(乙基亚硫酰基乙酰基)乙酰胺与四氟硼酸二甲基(甲基)硫代on(DMTSF)的反应。用DMTSF处理数种双-乙基亚磺酰胺通过相关方法以高收率递送了新颖的螺-杂环作为单一非对映异构体。与该级联序列相关的收敛性和立体化学控制使其特别适合于天然产物支架的组装。一些初步的研究针对了甲基安息香和去甲异叶核苷。当将模型Z-en氨基亚砜33与对-TsOH一起加热时,作为单一非对映异
    DOI:
    10.1021/jo020083x
点击查看最新优质反应信息

文献信息

  • Rapid and diverse route to natural product-like biaryl ether containing macrocycles
    作者:Pierre Cristau、Jean-Pierre Vors、Jieping Zhu
    DOI:10.1016/j.tet.2003.08.031
    日期:2003.9
    four-component reaction and an intramolecular nucleophilic aromatic substitution (SNAr) has been developed for the rapid access to biaryl-ether containing macrocycles. In the course of this study, we documented that ammonium chloride can promote the Ugi-4CR in non-polar aprotic solvent (toluene) without the interference of an alternative Passerini reaction. Solid phase synthesis of macrocycles by this two-step
    涉及的Ugi四组分反应和分子内的亲核芳香取代(S两步序列Ñ AR)已被开发为快速访问包含大环化合物的二芳基-醚。在本研究过程中,我们记录了氯化铵可在非极性非质子传递溶剂(甲苯)中促进Ugi-4CR,而不会受到其他Passerini反应的干扰。还使用聚合物(Wang树脂)负载的α-(4'-氟-3'-硝基)苯乙基异氰基乙酸酯作为输入之一,开发了通过此两步序列的大环化合物的固相合成。
  • Tandem Pummerer/Mannich Cyclization Cascade of α-Sulfinylamides as a Method To Prepare Aza-Heterocycles
    作者:Albert Padwa、Todd M. Heidelbaugh、Jeffrey T. Kuethe、Michael S. McClure、Qiu Wang
    DOI:10.1021/jo020083x
    日期:2002.8.1
    particularly suited for the assembly of natural product scaffolds. Some preliminary studies were directed toward both mesembrine and deethylibophyllidine. When the model Z-enamido sulfoxide 33 was heated with p-TsOH, a 80% yield of tosylate 34 was obtained as a single diastereomer. In this case, the carbocation intermediate derived from cyclization onto the terminal pi-bond was trapped with p-TsOH from the least
    通过伯胺与酮的缩合,然后使所得的亚胺与乙基亚磺酰基乙酰氯反应,然后用高碘酸钠氧化,可以方便地制备一系列α-亚磺酰胺基。当用p-TsOH处理时,通过涉及初始Pummerer反应,随后将所得N-酰基亚胺离子随后环化到束缚的芳族环上的机理发生环化以产生稠合的异喹啉内酰胺。根据Nazarov型4pi-电环反应,然后将pi环化到N-酰基亚胺离子受阻最小的一侧,合理化了单个非对映异构体的分离。用于产生α-酰基硫鎓离子中间体的另一种方法涉及双(乙基亚硫酰基乙酰基)乙酰胺与四氟硼酸二甲基(甲基)硫代on(DMTSF)的反应。用DMTSF处理数种双-乙基亚磺酰胺通过相关方法以高收率递送了新颖的螺-杂环作为单一非对映异构体。与该级联序列相关的收敛性和立体化学控制使其特别适合于天然产物支架的组装。一些初步的研究针对了甲基安息香和去甲异叶核苷。当将模型Z-en氨基亚砜33与对-TsOH一起加热时,作为单一非对映异
  • Identification of 3,4-Dihydroisoquinoline-2(1<i>H</i>)-sulfonamides as Potent Carbonic Anhydrase Inhibitors: Synthesis, Biological Evaluation, and Enzyme−Ligand X-ray Studies
    作者:Rosaria Gitto、Stefano Agnello、Stefania Ferro、Laura De Luca、Daniela Vullo、Jiri Brynda、Pavel Mader、Claudiu T. Supuran、Alba Chimirri
    DOI:10.1021/jm9014026
    日期:2010.3.25
    Following previous studies we herein report the exploration of the carbonic anhydrase (CA, EC 4.2.1.1) inhibitory effects and enzyme selectivity of a small class of 1-(cyclo)alkylisoquinolines containing a sulfonamide function considered a key feature for inhibiting CA. The results of enzymatic assays against human (h) CA isoforms, hCA I and hCA II (cytosolic, ubiquitous enzymes), hCA IX (transmembrane, tumor-associated), and hCA XIV (transmembrane), suggested that the presence of C-1 small substituents on isoquinoline scaffold controls both inhibitory potency and selectivity. Some derivatives showed potent hCA IX and hCA. XIV inhibitory effects at nanomolar concentrations as well as low affinity for the ubiquitous hCA II. Moreover, we report the X-ray crystal structure of one of these derivatives in complex with dominant human isoform II, thus confirming the sulfonamide zinc interactions. Finally, the results of docking experiments suggested the hypothetic interactions in the catalytic binding site for the most active and selective hCA IX and hCA XIV inhibitor.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐